Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)

Bicycle Therapeutics (BCYC) has 7 years of Current Leases data on file, last reported at $2.6 million in Q4 2025.

• Quarterly Current Leases fell 52.12% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (down 52.12% YoY) and the FY2025 annual result came in at $2.6 million, down 52.12% from the prior year.
• Current Leases slipped to $2.6 million in Q4 2025, from $5.2 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $5.5 million in Q1 2025 to a low of $708000.0 in Q1 2021.
• A 5-year average of $3.7 million and a median of $4.7 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases surged 323.16% — and 2025, when it slumped 52.12%.
• Tracing BCYC's Current Leases over 5 years: stood at $2.4 million in 2021, then soared by 31.14% to $3.1 million in 2022, then jumped by 56.03% to $4.9 million in 2023, then grew by 9.27% to $5.3 million in 2024, then tumbled by 52.12% to $2.6 million in 2025.
• The last three Current Leases figures came in at $2.6 million (Q4 2025), $5.2 million (Q2 2025), and $5.5 million (Q1 2025), per Business Quant data.